1. Objectives: In order to obtain high-quality pharmacokinetic (PK)/biomarker/antibody/pharmacogenomics (PGx) data from a clinical study, take charge of series of work concerning PK/biomarker/ antibody/PGx assay and oversight assay sites in order to execute these duties. In addition